Mesoporous Silica Nanoparticles as Drug Delivery Systems

Area of Science:

• Materials Science
• Nanotechnology
• Pharmaceutical Sciences

Background:

• Mesoporous silica nanocarriers (MSNs) are advanced materials for drug delivery.
• Their porous structure offers unique advantages for encapsulating active pharmaceutical ingredients (APIs).

Purpose of the Study:

• To review recent findings on MSNs for therapeutic and drug formulation applications.
• To highlight the role of MSN characteristics in drug delivery and targeted therapy.

Main Methods:

• Review of literature on MSNs in drug delivery.
• Analysis of MSN properties such as pore size, surface chemistry, and particle size.
• Examination of functionalization strategies for targeted delivery.

Main Results:

• MSNs improve API aqueous solubility and stability by forming an amorphous state.
• Encapsulation within MSNs protects drugs from degradation, enhancing bioavailability.
• MSN functionalization allows for organ-, tissue-, or cell-specific targeted delivery.
• Particle size and surface properties influence cell membrane interactions, epithelial permeability, and drug release rates.

Conclusions:

• MSNs represent a promising platform for developing advanced drug delivery systems.
• Their tunable properties facilitate enhanced drug solubility, stability, and targeted delivery.
• MSNs offer potential for improved therapeutic efficacy and reduced drug-related side effects.